Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child

Teratology. 2001 Feb;63(2):106-12. doi: 10.1002/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R.

Author

R L Brent¹

Affiliation

¹ Thomas Jefferson University and du Pont Hospital for Children, Wilmington, Delaware 19899, USA. rbrent@nemours.org

PMID: 11241434
DOI: 10.1002/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R

No abstract available

MeSH terms

Animals
Breast Feeding
Carcinogenicity Tests
Female
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / pharmacokinetics
Isoxazoles / adverse effects*
Isoxazoles / pharmacokinetics
Leflunomide
Male
Maternal Exposure
Mutagenicity Tests
Paternal Exposure
Pregnancy
Pyridines / antagonists & inhibitors
Teratogens*

Substances

Immunosuppressive Agents
Isoxazoles
Pyridines
Teratogens
Leflunomide